Pheno.AI
AI-powered healthcare platform using phenotypic analysis and machine learning to discover biomarkers and accelerate drug development through comprehensive patient phenotyping.
Website
https://pheno.aiLocation
Tel Aviv, Israel
Founded
2019
Investors
2
Categories
ai-drug-discovery, healthcare-platform, phenomics, biomarkers
Notes
Pheno.AI is an AI-powered healthcare platform that uses phenotypic analysis and machine learning to discover biomarkers and accelerate drug development. The company's platform enables comprehensive patient phenotyping by integrating and analyzing diverse health data sources.
Pheno.AI's technology helps pharmaceutical companies identify patient populations, discover biomarkers, and optimize clinical trial design through AI-driven insights.
Team
- Leadership team with expertise in AI, healthcare, and data science
Additional Research Findings
- Founded in 2019 in Tel Aviv, Israel
- Participating investor: Communitas Capital
- B2B SaaS focus for pharmaceutical and healthcare clients
- AI/ML platform for phenotypic analysis
- Applications in drug discovery and clinical trials
- Biomarker discovery capabilities
- Part of Israeli AI/healthtech ecosystem
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Communitas Capital | Boston, USA | generalist | seedseries-a+1 | 1 |
| Corundum Systems Biology | Tokyo, Japan | biotech-focused | seedseries-a+1 | 9 |